Press release from PR Newswire
PDL BioPharma to Present at Upcoming Investor Conferences
Thursday, May 30, 2013
PDL BioPharma to Present at Upcoming Investor Conferences07:00 EDT Thursday, May 30, 2013
INCLINE VILLAGE, Nev., May 30, 2013 /PRNewswire/ -- PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced that John P. McLaughlin, the company's president and chief executive officer, will present at the following upcoming conferences.
Jefferies 2013 Global Healthcare ConferenceThursday, June 6, 20139:30 a.m. ETNew York City
Goldman Sachs 34th Annual Global Healthcare ConferenceTuesday, June 11, 201310:40 a.m. PTRancho Palos Verdes, CA
To access the live and subsequently archived webcasts of the presentations, go to the Company's website at http://www.pdl.com and go to "Events and Presentations." Please connect to the website at least 15 minutes prior to the call to allow for any software download that may be necessary. The archived webcast will be available for seven days following each presentation.
About PDL BioPharmaPDL pioneered the humanization of monoclonal antibodies and, by doing so, enabled the discovery of a new generation of targeted treatments for cancer and immunologic diseases. Today, PDL is focused on intellectual property asset management, investing in new income generating assets and maximizing value for its shareholders. For more information, please visit www.pdl.com.
NOTE: PDL BioPharma and the PDL BioPharma logo are considered trademarks of PDL BioPharma, Inc.
SOURCE PDL BioPharma, Inc.
For further information: Peter Garcia, PDL BioPharma Inc., 775-832-8500, email@example.com or Jennifer Williams, Cook Williams Communications, 360-668-3701, firstname.lastname@example.org